ESC 365 - Why should we treat mitral regurgitation?

HFA Premium Access

Why should we treat mitral regurgitation?

Session: Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?

Topic: Valvular heart disease

Speaker: Professor M. Senni (Bergamo, IT)

Sponsored by Abbott Vascular

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)

50 presentations

4 followers

5 more presentations in this session

Introduction.

Speaker: Professor F. Ruschitzka (Zurich, CH)

Functional mitral regurgitation patients: when to treat them with transcatheter mitral valve repair?

Speaker: Professor O. Alfieri (Milan, IT)

More than 30000 patients treated with transcatheter mitral valve repair, can we talk about survival benefit?

Speaker: Professor R. von Bardeleben (Mainz, DE)

Functional mitral regurgitation patients: how transcatheter mitral valve repair improve their quality of life?

Speaker: Professor J. Trochu (Nantes, FR)

Take home message.

Speaker: Professor F. Ruschitzka (Zurich, CH)

Access the full session

Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?

Speakers: Professor M. Senni, Professor F. Ruschitzka, Professor O. Alfieri, Professor R. von Bardeleben, Professor J. Trochu...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources